Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitamin A Oral Supplementation as a Preventive Treatment for Chronic Lung Disease Among Infants Born Before 29 Weeks of Gestation.

NCT04563429 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT04563429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04563429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitamin A Oral Supplementation as a Preventive Treatment for Chronic Lung Disease Among Infants Born Before 29 Weeks of Gestation.
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2020
Completion date
October 1, 2023
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

the relationship between oral vitamin a administration and the incidence of bpd in preterm infants born before week 29 of pregnancy